Savant Capital, LLC Standard Biotools Inc. Transaction History
Savant Capital, LLC
- $13.2 Billion
- Q1 2025
A detailed history of Savant Capital, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 19,031 shares of LAB stock, worth $20,553. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,031Holding current value
$20,553% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
151Shares Held
280MCall Options Held
6KPut Options Held
36.6K-
Casdin Capital, LLC New York, NY76.1MShares$82.2 Million9.61% of portfolio
-
Viking Global Investors LP58.7MShares$63.3 Million0.21% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$23.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$18.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$11.6 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $84.9M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...